Abstract
ABSTRACTPurpose:To provide a summary and recommendations for the set-up of strategies for cancer patients care in genitourinary oncology clinics during the pandemic and in the recovery period.Material and Methods:A non-systematic review of available literature on the management of urological malignancies during the COVID-19 pandemic was performed to summarize recommendations to improve the diagnosis and treatment of urological cancers during and after the contingence, including clinical and research aspects.Results:Urological cancer diagnosis and management should be tailored according to the severity of the COVID-19 crisis in each region and the aggressiveness of each tumor. Clinicians should adhere to strict protocols in order to prioritize the attention of patients with high-risk malignancies while optimizing resources to avoid the saturation of critical care services.Conclusions:During the COVID-19 pandemic urological cancer care has been severely impaired. For proper patient management, multidisciplinary approach is encouraged tailoring therapy according to COVID-19 regional behavior and local institutional resources. Patients with high-risk malignancies should be prioritized.
Highlights
In recent months, the new coronavirus (SARS-CoV-2) disease (COVID-19) became an epidemiological phenomenon that has overwhelmed health care systems globally (1)
Our objective is to provide some recommendations for the set-up of strategies for cancer patients care in Genito-Urinary Oncology (GUO) clinics during the pandemic as well as in the recovery period, considering that some modifications implemented to consultation areas, schedules and facilities might be in place for a while
We explored Pubmed database, American Confederation of Urology (CAU) library, European Association of Urology (EAU) recommendations, American Urological Association (AUA) COVID-19 Information Center and American Society of Clinical Oncology (ASCO) Coronavirus resources looking for publications on the aforementioned topics
Summary
The new coronavirus (SARS-CoV-2) disease (COVID-19) became an epidemiological phenomenon that has overwhelmed health care systems globally (1). The negative impact of this pandemic has involved multiple aspects of clinical practice and health services all around the World, including Genito-Urinary Oncology (GUO) clinics. The consequences of this crisis on cancer patients care is two-fold: a) those diagnosed shortly before or during the outbreak will experience a delay on their treatment; b) new patients with potentially high-risk malignancies will undergo a delayed diagnostic process with the inherent risks due to late approach and therapy, such as progression and losing the chance of curability. Our objective is to provide some recommendations for the set-up of strategies for cancer patients care in GUO clinics during the pandemic as well as in the recovery period, considering that some modifications implemented to consultation areas, schedules and facilities might be in place for a while
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
